We propose a Phase II program using toxins from parasitic wasps to develop methods for guiding the discovery of improved, highly selective chemical insecticides. The proposed program involves identifying at least two highly insecticidal, highly insect-selective toxins from parasitic wasp venoms, and using them as ligands for the development of high throughput receptor binding assays. Several suitable candidate venoms, with at least two distinct modes of action, were identified in Phase I and methods for purifying their active components are under development. In Phase II, these toxins will be radioactively labeled and used as radioligands to define the pharmacology of their target sites. All biological assays and receptor binding assays will be developed with a major agricultural pest, the tobacco budworm. Using highly selective toxins with great insecticidal potency in the ultimate target pest, and using the target pest for further assay development, is the definite aspect of the proposed program. Most efforts to employ receptor binding assays in insecticide discovery have involved the use of receptor preparations and ligands with questionable relevance. The research we propose, in contrast, will develop assay systems that are specifically relevant for a major crop pest.
Anticipated Results:Successful completion of Phase II will provide new receptor binding assays for measuring chemical activity at target sites defined by toxins having great insecticidal potency and great selectivity for insects. These assays will be suitable for screening libraries of small organic molecules in Phase III, to identify molecules with significant activity at these target sites. Because they will use tissues from a major pest (the tobacco budworm), and toxins with high insecticidal activity in this pest, these assays will be of unique value in the discovery of effective chemical insecticides with improved environmental characteristics.